Chemours Cash & Equivalents History
CC / Materials|10 years of SEC 10-K data (FY2016-FY2025)
$670M in FY2025 with a 5-year CAGR of -9.5%. Top quartile in the Materials sector.
Declined from $1.2B to $670M over the past 2 years.
Chemours's cash & equivalents of $670M is higher than 76% of companies in the Materials sector (FY2025). Cash & Equivalents has fluctuated over the past 10 years, ranging from $670M in FY2025 to $1.6B in FY2017.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 1.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
- 3-Year CAGR
- -15.3%
- 5-Year CAGR
- -9.5%
- 10-Year CAGR
- -
Cash & Equivalents Trend
Top 24% in MaterialsTop 24% of 114This company $670.0M Sector average $695.8M
▼
-3.7% below sector average
Key Insights
- 5-year CAGR of -9.5%, indicating a declining trend.
- In FY2025, cash & equivalents decreased 6.0% year-over-year.
- Ranks #27 out of 114 companies in the Materials sector.
- Peak cash & equivalents was recorded in FY2017.
Annual Data
| Year | Cash & Equivalents | YoY Growth |
|---|---|---|
| FY2025 | $670.0M | -6.0% |
| FY2024 | $713.0M | -40.7% |
| FY2023 | $1.2B | +9.2% |
| FY2022 | $1.1B | -24.1% |
| FY2021 | $1.5B | +31.3% |
| FY2020 | $1.1B | +17.2% |
| FY2019 | $943.0M | -21.5% |
| FY2018 | $1.2B | -22.8% |
| FY2017 | $1.6B | +72.5% |
| FY2016 | $902.0M | +146.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026